| The production processes and biological effects of intravenous immunoglobulin AF Barahona Afonso, CMP João Biomolecules 6 (1), 15, 2016 | 110 | 2016 |
| The immune microenvironment in multiple myeloma: friend or foe? R Lopes, J Caetano, B Ferreira, F Barahona, EA Carneiro, C Joao Cancers 13 (4), 625, 2021 | 37 | 2021 |
| Liquid biopsies for multiple myeloma in a time of precision medicine B Ferreira, J Caetano, F Barahona, R Lopes, E Carneiro, B Costa-Silva, ... Journal of Molecular Medicine 98, 513-525, 2020 | 25 | 2020 |
| Boosting immunity against multiple myeloma R Lopes, BV Ferreira, J Caetano, F Barahona, EA Carneiro, C João Cancers 13 (6), 1221, 2021 | 10 | 2021 |
| Multiple myeloma-derived extracellular vesicles modulate the bone marrow immune microenvironment R Lopes, J Caetano, F Barahona, C Pestana, BV Ferreira, D Lourenço, ... Frontiers in Immunology 13, 909880, 2022 | 7 | 2022 |
| Treatment with low doses of polyclonal immunoglobulin improves B cell function during immune reconstitution in a murine model AB Afonso, LN Justo, AC Queirós, C Fesel, MS Cabral, MG Da Silva, ... Journal of clinical immunology 33, 407-419, 2013 | 5 | 2013 |
| The production processes and biological effects of intravenous immunoglobulin. Biomolecules. 2016; 6: 15 AF Barahona Afonso, CM Joao | 5 | |
| Patient-derived extracellular vesicles proteins as new biomarkers in multiple myeloma-A real-world study BV Ferreira, EA Carneiro, C Pestana, F Barahona, J Caetano, R Lopes, ... Frontiers in Oncology 12, 860849, 2022 | 3 | 2022 |
| Measurable residual disease assessment in multiple myeloma: how deep is enough? J Caetano, F Barahona, P Lúcio, C João Hemato 3 (3), 385-413, 2022 | 2 | 2022 |
| IMMUNE RECONSTITUTION IN PATIENTS WIHT B-NON HODGKIN LYMPHOMA (B-NHL) TREATED WITH RITUXIMAB, CHEMOTHERAPY OR BOTH-A COHORT STUDY A Afonso Haematologica-the Hematology Journal 95, 617-618, 2010 | 2 | 2010 |
| Is Circulating DNA and Tumor Cells in Myeloma the Way Forward? E Arnault Carneiro, F Barahona, C Pestana, C João Hemato 3 (1), 63-81, 2022 | 1 | 2022 |
| Statistical methods for the study of extracellular vesicles content and their potential as biomarkers of multiple myeloma aggressiveness CF Pestana, L Sousa, E Carneiro, F Barahona, J Caetano, R Lopes, ... Journal of Statistics on Health Decision 2 (2), 47-48, 2020 | 1 | 2020 |
| P821: HIGH-DIMENSIONAL SPECTRAL CYTOMETRY CHARACTERIZATION OF THE CIRCULATING IMMUNE CELL PROFILE IN ASYMPTOMATIC AND SYMPTOMATIC MYELOMA PATIENTS. J Caetano, F Barahona, M Neves, BV Ferreira, S Leocádio, A Queirós, ... HemaSphere 7 (S3), e54601b9, 2023 | | 2023 |
| P841: EXTRACELLULAR VESICLE PROTEINS AS BIOMARKER OF OUTCOME IN MULTIPLE MYELOMA-A REAL-WORLD STUDY EA Carneiro, B Ferreira, C Pestana, F Barahona, J Caetano, R Lopes, ... HemaSphere 6, 735-736, 2022 | | 2022 |
| PS1364 EXOSOMAL CARGO IN MONOCLONAL GAMMOPATHIES COMPARED TO HEALTHY DONORS AND ITS POTENTIAL RELATION TO MYELOMA AGGRESSIVENESS B Ferreira, E Carneiro, F Barahona, P Lucio, M Neves, B Costa-Silva, ... HemaSphere 3 (S1), 623, 2019 | | 2019 |
| IMMUNOGLOBULIN TREATMENT IMPROVES RECONSTITUTION OF B CELL COMPARTMENT AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION L Justo, A Afonso, A Queiros, C Fesel, M Cabral, A Pires, C Joao HAEMATOLOGICA 95, 302-302, 2010 | | 2010 |
